机构:[1]Department of Radiation Oncology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China,[2]Department of Oncology, Huanggang Central Hospital, Huanggang, China,[3]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Sichuan, China,[4]Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Medical College of Nanchang University, Nanchang, China
The author(s) declare that financial support was received for the
research and/or publication of this article. This work was supported
by the National Natural Science Foundation of China (No.
82260607, 81760547), the Science and Technology Project of
Jiangxi Province (No. 20212BAB206065, 20242BAB26138), and
outstanding youth of Jiangxi Cancer hospital (No.2021DYS02),
High-level and high-skill leading talents of Jiangxi Province
(GCSG2002001). The Open Fund for Scientific Research of
Jiangxi Cancer Hospital (No:2021J15), the Gulin County People’s
Hospital-The Affiliated Hospital of Southwest Medical University
Science and Technology Strategic Cooperation Project
(2022GLXNYDFY05), The Xuyong County People’s Hospital-
Southwest Medical University Science and Technology Strategic
Cooperation Project (2024XYXNYD05).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|3 区医学
小类|4 区肿瘤学
最新[2025]版:
大类|3 区医学
小类|4 区肿瘤学
第一作者:
第一作者机构:[1]Department of Radiation Oncology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China,
共同第一作者:
通讯作者:
通讯机构:[1]Department of Radiation Oncology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China,[4]Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Medical College of Nanchang University, Nanchang, China
推荐引用方式(GB/T 7714):
Zhang Huai-Wen,Feng Liu,Pang Hao-Wen,et al.A nomogram with the peripheral blood neutrophil-to-lymphocyte ratio before treatment predicts the survival of patients with nasopharyngeal carcinoma[J].Frontiers In Oncology.2025,15:1469191.doi:10.3389/fonc.2025.1469191.
APA:
Zhang Huai-Wen,Feng Liu,Pang Hao-Wen,Yu Teng-Hua,Lu Tian-Zhu...&Jiang Chun-Ling.(2025).A nomogram with the peripheral blood neutrophil-to-lymphocyte ratio before treatment predicts the survival of patients with nasopharyngeal carcinoma.Frontiers In Oncology,15,
MLA:
Zhang Huai-Wen,et al."A nomogram with the peripheral blood neutrophil-to-lymphocyte ratio before treatment predicts the survival of patients with nasopharyngeal carcinoma".Frontiers In Oncology 15.(2025):1469191